Preliminary results from Brazil's first recovery housing program
Dados preliminares do primeiro programa de moradia monitorada no Brasil
Dhione Almeida do Carmo; Sonia Maria Motta Palma; Ariadne Ribeiro; Alisson Paulino Trevizol; Elisa Brietzke; Renata Rigacci Abdalla; Ana Leonor Sala Alonso; Claudio Jerónimo da Silva; Quirino Cordeiro; Ronaldo Laranjeira; Marcelo Ribeiro
Abstract
Keywords
Resumo
Palavras-chave
References
Ribeiro M, Duailibi S, Frajzinger R, Alonso AL, Marchetti L, Williams AV. The Brazilian "Cracolandia" open drug scene and the challenge of implementing a comprehensive and effective drug policy. Addiction. 2016;111:571-3.
Polcin DL, Korcha R, Bond J, Galloway G. Eighteen-month outcomes for clients receiving combined outpatient treatment and sober living houses. J Subst Use. 2010;15:352-66.
Best D, O'Grady A, Charalampous I, Gordon G. National needs assessment for tier 4 drug services in England. 2006.
Models of residential rehabilitation for drug and alcohol misusers. 2006:17-8.
Booth R. Alcohol halfway houses: treatment length and treatment outcome. Int J Addiction. 1981;16:927-34.
Davis S. Effects of chemical dependency in parenting women. Addictive behaviors in women. 1994:381-414.
Wolle CC, Sanches M, Zilberman ML, Caetano R, Zaleski M, Laranjeira RR. Differences in drinking patterns between men and women in Brazil. Rev Bras Psiquiatr. 2011;33:367-73.
Zilberman M, Tavares H, el-Guebaly N. Gender differences and similarities: prevalence and course of alcohol and other substance related disorders. J Addict Dis. 2003;22:61-74.
Gigliotti A, Guimarães A. Dependência, compulsão e impulsividade. A mulher e a dependência química sob uma perspectiva feminina. 2007:19-30.
Kandall SR. Women and drug addiction: a historical perspective. J Addict Dis. 2010;29:117-26.
Ribeiro M, Laranjeira R. O tratamento do usuário de crack. 2012:585-98.
Horta RL, Vieira LS, Balbinot AD, de Oliveira GO, Poletto S, Teixeira VA. Families and crack cocaine consumption. J Bras Psiquiatr. 2014;63:104-12.
Chutuape MA, Jasinski DR, Fingerhood MI, Stitzer ML. One, three-, and six-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse. 2001;27:19-44.
Shaham Y, Shalev U, Lu L, De Wit H, Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl). 2003;168:3-20.
Laudet AB, White W. What are your priorities right now? Identifying service needs across recovery stages to inform service development. J Subst Abuse Treat. 2010;38:51-9.
Laranjeira R, Elbreder M, Ribeiro M. Moradia assistida para dependentes químicos. O tratamento do usuário de crack, avaliação clínica, psicossocial, neuropsicológica, e de risco. 2010:337-42.
Larimer ME, Malone DK, Garner MD, Atkins DC, Burlingham B, Lonczak HS. Health care and public service use and costs before and after provision of housing for chronically homeless persons with severe alcohol problems. JAMA. 2009;301:1349-57.
Milby JB, Schumacher JE, Wallace D, Freedman MJ, Vuchinich RE. To house or not to house: the effects of providing housing to homeless substance abusers in treatment. Am J Public Health. 2005;95:1259-65.
Jason LA, Olson BD, Ferrari JR, Lo Sasso AT. Communal housing settings enhance substance abuse recovery. Am J Public Health. 2006;96:1727-9.
Jason LA, Davis MI, Ferrari JR. The need for substance abuse after-care: longitudinal analysis of Oxford House. Addict Behav. 2007;32:803-18.
Milby JB, Schumacher JE, McNamara C, Wallace D, Usdan S, McGill T. Initiating abstinence in cocaine abusing dually diagnosed homeless persons. Drug Alcohol Depend. 2000;60:55-67.
Schumacher JE, Milby JB, Wallace D, Meehan D-C, Kertesz S, Vuchinich R. Meta-analysis of day treatment and contingency-management dismantling research: Birmingham Homeless Cocaine Studies (1990-2006). J Consult Clin Psychol. 2007;75:823-8.
Tuten M, DeFulio A, Jones HE, Stitzer M. Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification. Addiction. 2012;107:973-82.
West LJ, Ackerman D. The drug-testing controversy. J Drug Issues. 1993;23:579-95.